News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,375 Results
Type
Article (14394)
Company Profile (110)
Press Release (281871)
Section
Business (97603)
Career Advice (474)
Deals (17466)
Drug Delivery (64)
Drug Development (39979)
Employer Resources (49)
FDA (7069)
Job Trends (6570)
News (166495)
Policy (15487)
Tag
Academia (507)
Alliances (26630)
Alzheimer's disease (423)
Approvals (7073)
Artificial intelligence (69)
Bankruptcy (145)
Best Places to Work (4661)
Biotechnology (46)
Breast cancer (66)
Cancer (466)
Career advice (415)
Cell therapy (68)
Clinical research (33352)
Collaboration (212)
Compensation (80)
COVID-19 (851)
C-suite (60)
Data (495)
Diabetes (66)
Diagnostics (1713)
Drug discovery (44)
Drug pricing (59)
Earnings (35248)
Events (40951)
Executive appointments (225)
FDA (7333)
Funding (148)
Gene therapy (72)
GLP-1 (310)
Government (1401)
Healthcare (4219)
Infectious disease (873)
Inflammatory bowel disease (54)
Interviews (58)
IPO (6711)
Job creations (2133)
Job search strategy (381)
Layoffs (170)
Legal (3768)
Lung cancer (64)
Manufacturing (122)
Medical device (2247)
Medtech (2250)
Mergers & acquisitions (10843)
Metabolic disorders (199)
Neuroscience (545)
NextGen Class of 2024 (1715)
Non-profit (653)
Northern California (553)
Obesity (114)
Opinion (112)
Patents (65)
People (30498)
Pharmaceutical (67)
Phase I (8851)
Phase II (14217)
Phase III (12453)
Pipeline (223)
Policy (47)
Postmarket research (1448)
Preclinical (3534)
Radiopharmaceuticals (128)
Rare diseases (112)
Real estate (2918)
Regulatory (10926)
Research institute (633)
Resumes & cover letters (56)
Southern California (538)
Startups (1851)
United States (5310)
Vaccines (129)
Weight loss (81)
Date
Last 7 days (250)
Last 30 days (896)
Last 365 days (14145)
2024 (14077)
2023 (16236)
2022 (22887)
2021 (23451)
2020 (22023)
2019 (16795)
2018 (13113)
2017 (15489)
2016 (14675)
2015 (17286)
2014 (13960)
2013 (11979)
2012 (12879)
2011 (13382)
2010 (12146)
Location
Africa (337)
Arizona (44)
Asia (30587)
Australia (3954)
California (1280)
Canada (743)
China (183)
Colorado (47)
Connecticut (52)
Europe (45063)
Florida (184)
Illinois (140)
Indiana (96)
Japan (65)
Kansas (55)
Maryland (219)
Massachusetts (1080)
Minnesota (83)
New Jersey (543)
New York (372)
North Carolina (317)
Northern California (553)
Pennsylvania (332)
South America (549)
Southern California (538)
Texas (165)
Virginia (45)
Washington State (80)
296,375 Results for "beacon pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
Beacon Biosignals announced a strategic partnership with Longboard Pharmaceuticals, Inc. that combines Longboard’s drug development expertise with Beacon’s neurophysiological platform to develop a better understanding of the relationship between sleep and neurological conditions with an initial focus in rare epileptic syndromes.
May 13, 2024
·
2 min read
Press Releases
Beacon Biosignals Reports Novel Sleep EEG Results from Multiple Industry Collaborations at the American Epilepsy Society Annual Meeting
December 12, 2024
·
4 min read
Genetown
Beacon Therapeutics Treats First Patient in VISTA Registrational Trial for AGTC-501
Beacon Therapeutics Holdings Limited, a leading ophthalmic gene therapy company with a mission to save and restore the vision of patients with blinding retinal diseases, announced the treatment of the first patient in its registrational VISTA clinical trial with its lead asset, AGTC-501.
June 12, 2024
·
3 min read
Press Releases
Chang Gung Memorial Hospital Unveils Cellular Therapy: A Beacon of Hope for Cancer Treatment
October 21, 2024
·
3 min read
Press Releases
Beacon Therapeutics Announces Positive 3-Month Data from Phase 2 DAWN Trial of laru-zova (AGTC-501) in Patients with X-Linked Retinitis Pigmentosa (XLRP)
December 9, 2024
·
4 min read
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
Press Releases
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
December 3, 2024
·
15 min read
Press Releases
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
·
1 min read
Drug Development
Beacon Therapeutics Announces Positive 24-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis Pigmentosa
October 15, 2024
·
4 min read
Press Releases
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
November 11, 2024
·
4 min read
1 of 29,638
Next
